Epilepsy and remission in primary care level
Main Article Content
Keywords
epilepsy, nervous system diseases
Abstract
Objective: to identify the epilepsy remission period in a primary care unit.
Methods: there were 330 patients with diagnosis of epilepsy in remission according to the international criteria treated in a Primary Care Unit of the Instituto Mexicano del Seguro Social, Xalapa, Veracruz; There were 216 patients who were controlled (without epilepsy crisis) 150 of them were interviewed with a structure instrument designed for this purpose.
Results: the history of epilepsy was from five to nine years (49 %). Partial crisis was identified in 54 %. The age of diagnosis was established in 44% between one to ten years. The patients received drug treatment during a period of three to eight years in 51 % of them. The monotherapy was used in 51 % of the cases.
Conclusions: remission of epilepsy crisis can be obtained in most patients with two years drug treatment. However, we can not talk about definitive cure.
References
Carrizosa MJ, Cornejo OW. Epilepsia curada y controlada. Rev Mex Neuroci 2004;5(4):319-324.
Reséndiz AJ, Rodríguez RE, Contreras BJ, Ceja MH, Barragán PE, Garza MS, et al. Estudio abierto aleatorio y comparativo de la monoterapia con topiramato frente a carbamazepina en el tratamiento de pacientes pediátricos con epilepsia de reciente diagnóstico. Rev Neurol 2004;39(3): 201-204.
Corredera GE, Gómez AJ, Arias M, Seijo MM, Rodríguez J, Rubio NE, López F. Tratamiento com topiramato em pacientes com epilepsia refractaria. Ver Neurol 2003;37(5):401-404.
Hauser A. Prognosis of epilepsy; the Rochester studies. En: Jallon P, editor. Prognosis of epilepsies. Paris: John Lebbey Eutotext; 2003. p. 55-63.
Linsten H, Stenlund H, Forsgren L. Remission of seizures in a population based adult cohort with a newly diagnosed unprovoked epileptic seizure. Epilepsia 2001;42(8):1025-1030.
Ramos LJ, Cansinello GE, Vázquez LM, Carrasco MML, Muñoz HA, Martín GM. Remisión a largo plazo de la epilepsia en la infancia estudio prospectivo. Rev Neurol 2002;34(9):824-829.
Santiago RE, Sales CV, Ramos RR. Factores de riesgo para incumplimiento terapéutico en pacientes con epilepsias. Gac Med Mex 2002;139 (3):241-246.
Arroyo S. Evaluación de la epilepsia farmaco-rresistente. Rev Neurol 2000;30(9):881-886.
Sancho RJ, López T. Pronóstico de las epilepsias. Rev Neurol 2000;30(4):333-336.
Castro-Sánchez A. El apoyo social en la enfermedad crónica: el caso de los pacientes diabéticos tipo 2. Rev Salud Publica Nutr 2006;7(4).
Pérez PJ, Sosa AM, González CS. Conocimiento, control clínico y actitudes de los médicos de atención primaria frente a los pacientes epilépticos. Rev Neurol 2005;40(7):385-393.
Argumosa A, Herranz JL. El coste económico de la epilepsia infantil en España. Rev Neurol 2000;30(2):104-108.